Spinal Stimulation and Mobility Devices for Neurological Conditions

This study is looking at how non-invasive spinal stimulation (a device that gently stimulates your spine at the neck or lower back) and mobility devices (like walkers or braces) affect movement in people with neurological conditions such as Cerebral Palsy, Stroke, Premature Birth, Hypoxic-Ischemic Encephalopathy, or Periventricular Leukomalacia. Researchers want to see if using these methods, alone or together, can improve muscle coordination during walking. You can join if you are between 4 and 70 years old, have a stable neurological condition, can follow simple commands, and are willing to provide feedback. The study aims to enroll 20 participants, but its current status is unclear.

Study design: This is an interventional study with an unclear phase, planning to enroll 20 participants. It will examine the effects of Mobility Devices and Spinal Stimulation.
What's involved: You will use a mobility device and/or receive spinal stimulation during study sessions. You will also provide feedback on your comfort and experience during lab visits.
Compensation: Not stated in the trial record.
Follow-up: Muscle coordination will be measured by comparing the first and last minute of walking on a treadmill at each experimental session.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

Spinal Stimulation and Mobility Devices

Recruiting

NAAges 4–70InterventionalBasic science

University of Washington

~20 participants

Updated 2025-08-13 on ClinicalTrials.gov

What's tested:Mobility DeviceSpinal Stimulation

At a glance

Recruiting sites

1 of 1 listed site is recruiting right now

RecruitingSuspended, closed, or not yet open

What they're measuring

Muscle Coordination

Measured over Comparing first and last minute of walking on treadmill at each experimental session.

Conditions

Cerebral Palsy

Stroke

Premature Birth

Hypoxic-Ischemic Encephalopathy

Periventricular Leukomalacia

Where it's being run

1 sites across 1 states

Washington1

Study leadership

Katherine Steele, PHD · PRINCIPAL_INVESTIGATOR · University of Washington

Who to contact

Katherine Steele, PHD

[email protected]

206-685-2390

Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime

Eligibility criteria

Inclusion

have a neurologic condition

are 4-70 years of age

have stable medical condition

can perform simple cued motor tasks and who can follow 2-3 step commands

who are volunteering to be involved in this study

can provide feedback on comfort and experience during lab visits

Exclusion

have significant medical disease; including uncontrolled systemic hypertension with values above 170/100 mmHg; cardiac or pulmonary disease; uncorrected coagulation abnormalities or need for therapeutic anticoagulation.

have cardiovascular or musculoskeletal disease or injury that would prevent full participation in physical therapy intervention

have a history of uncontrolled seizures

have unhealed fracture or other musculoskeletal impairment that might interfere with lower extremity rehabilitation or testing activities

are dependent on ventilation support

have implanted stimulator (e.g. epidural stimulator, vagus nerve stimulator, pacemaker, cochlear implant, etc) or drug delivery device (e.g. baclofen pump)

have history of orthopedic surgery in lower extremities or neurosurgery that may be a confounding factor for interpretation of the results (such as tendon transfer, tendon or muscle lengthening for spasticity management, injection therapies to lower extremity muscles, etc.) in last 12 months

have established osteoporosis and taking medication for osteoporosis treatment.

have rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, etc.)

have active cancer

What this trial measures

Muscle CoordinationComparing first and last minute of walking on treadmill at each experimental session.
Change in level of co-contraction between the plantarflexor and tibialis anterior muscles during the gait cycle monitored from electromyography recordings.

Trialytics